Investing in Hope for Families Living with RVCL
The Clayco Foundation is committing $10 million to Penn Medicine to advance groundbreaking RVCL research, bringing new hope toward treatments for this rare genetic disease.
As quoted from the great movie Network, "We're mad as hell, and we're not gonna take it anymore!"
St. Louis doesn’t have the leadership it needs, and residents are rightfully fed up with the way it has been run for a long time. I joined nationally recognized Midwest radio talk show host McGraw Milhaven on KTRS 550am to discuss the challenges Clayco has experienced while trying to build in the area.
As a native Missourian, I saw a 16-acre vacant property and thought about the extraordinary work we could do in transforming that space into something revolutionary for the community. Unfortunately, the city said no.
St. Louis, we must do better for our neighborhoods and economy!

Go beyond the post. Subscribe to the newsletter.
A monthly recap of ideas, progress, and what’s ahead.